Daivonex Oint 50 mcg/gm 30 gm works by slowing the excessive production of skin cells.
Side effects
Major & minor side effects for Daivonex Oint 50 mcg/gm 30 gm

Excessive tiredness and weakness severe

Mental confusion severe

Loss of appetite severe

Mild to moderate depression severe

Nausea or vomiting

Constipation

Itching and skin rash

Difficulty in breathing severe

Swelling and redness at the application site

Burning or stinging sensation

Increased thirst severe

Increased urination frequency severe

Darkening of skin rare

Dandruff formation rare

Infection in the hair follicle

Dry mouth severe

Change in taste/ Metallic taste severe

Uses of Daivonex Oint 50 mcg/gm 30 gm
What is it prescribed for?

Plaque Psoriasis
This medicine is used for the treatment of a mild-to-moderate plaque psoriasis characterized by red, scaly, itchy, dry patches on the skin and the scalp due to the increased production of skin cells.

Concerns

Frequently asked questions

Onset of action
The amount of time taken by this medicine to show its effect is not clinically established. However, its effect is believed to be cumulative and improvement in symptoms is usually observed within 2 weeks of application.

Duration of Effect
The amount of time for which this medicine remains active in the body is not clinically established.

Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?
No habit-forming tendencies were reported.

Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, monitor the infant closely for any undesired side effects.

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to Daivonex Oint 50 mcg/gm 30 gm or any other inactive ingredient present in the formulation.

Calcium metabolism disorder
This medicine is not recommended for use in patients suffering from calcium metabolism disorders, resulting in higher or lower than normal levels of calcium in the body.

Severe liver/kidney damage
This medicine is not recommended for use in patients suffering from a severe impairment of liver or kidney function.

Use on face
This medicine is not recommended for use on the face.

Use in children below 6 years of age
This medicine is not recommended for use in children less than 6 years of age.

Warnings

Warnings for special population

Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding
This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, monitor the infant closely for any undesired side effects.

General Warnings

Other medicines
This medicine may interact with other medicines and may cause severe adverse effects. Hence, it is advised that you report all your current medicines, including any herbs and supplements, to the doctor before beginning treatment with this medicine.

Ultraviolet radiation treatment
This medicine should be used with extreme caution in patients receiving ultraviolet radiation treatment for psoriasis due to the increased risk of skin cancer. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Use in elderly
This medicine should be used with caution in the elderly patients since the risk of adverse effects is significantly higher. Appropriate dose adjustments may be necessary based on the clinical condition of the patient.

Use in children
This medicine is not recommended for use in children less than 6 years of age since the safety and efficacy of use are not clinically established. It should be used with extreme caution in children above 6 years of age since the risk of adverse effects is significantly higher. Your doctor will suggest appropriate dose adjustments to minimize the risk of side effects.

Use on the face
This medicine should not be applied on the face since severe itching, redness, or irritation may develop. Patients are advised to take precautions so that the medicine does not come into contact with the eyes or the face.

Hypercalcemia
This medicine should not be used in patients suffering from hypercalcemia (elevated blood calcium levels) or patients with an evidence of vitamin D toxicity since it may worsen the patient’s condition.

Exposure to sunlight
Patients are advised to avoid excessive exposure to sunlight (natural and artificial both) during treatment with this medicine. Appropriate precautionary measures should be taken while stepping outside at daytime.

Dosage

Missed Dose
Apply the missed dose as soon as possible. If it is almost time for the next scheduled application, then the missed dose can be skipped. Do not use extra medicine to make up for the missed dose.

Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions
Interaction with Medicines

calcium supplements

Calcium salts

General Instructions

Apply this medicine exactly as prescribed by the doctor. Do not use in smaller or larger quantities than recommended. Avoid contact with the eyes or face. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

References

pubchem –
Calcipotriol [Internet].
Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Calcipotriol#section=Top
[cited 12/30/2020].
2020

drugbank –
Calcipotriol [Internet].
Available from: https://go.drugbank.com/drugs/DB02300
[cited 12/30/2020].
2020